202 related articles for article (PubMed ID: 18926679)
1. Inhibitory mechanisms of Agaricus blazei Murill on the growth of prostate cancer in vitro and in vivo.
Yu CH; Kan SF; Shu CH; Lu TJ; Sun-Hwang L; Wang PS
J Nutr Biochem; 2009 Oct; 20(10):753-64. PubMed ID: 18926679
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of Agaricus blazei extracts on human myeloid leukemia cells.
Kim CF; Jiang JJ; Leung KN; Fung KP; Lau CB
J Ethnopharmacol; 2009 Mar; 122(2):320-6. PubMed ID: 19162153
[TBL] [Abstract][Full Text] [Related]
3. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.
Ng SS; MacPherson GR; Gütschow M; Eger K; Figg WD
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4192-7. PubMed ID: 15217957
[TBL] [Abstract][Full Text] [Related]
5. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ
Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029
[TBL] [Abstract][Full Text] [Related]
6. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
[TBL] [Abstract][Full Text] [Related]
7. White button mushroom (Agaricus bisporus) exhibits antiproliferative and proapoptotic properties and inhibits prostate tumor growth in athymic mice.
Adams LS; Phung S; Wu X; Ki L; Chen S
Nutr Cancer; 2008; 60(6):744-56. PubMed ID: 19005974
[TBL] [Abstract][Full Text] [Related]
8. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice.
Khor TO; Keum YS; Lin W; Kim JH; Hu R; Shen G; Xu C; Gopalakrishnan A; Reddy B; Zheng X; Conney AH; Kong AN
Cancer Res; 2006 Jan; 66(2):613-21. PubMed ID: 16423986
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of herbal supplements in human prostate cancer xenografts implanted in immunodeficient mice.
Ng SS; Figg WD
Anticancer Res; 2003; 23(5A):3585-90. PubMed ID: 14666653
[TBL] [Abstract][Full Text] [Related]
11. S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions.
Chu Q; Lee DT; Tsao SW; Wang X; Wong YC
BJU Int; 2007 Apr; 99(4):925-32. PubMed ID: 17155983
[TBL] [Abstract][Full Text] [Related]
12. Screening for in vitro and in vivo antitumor activities of the mushroom Agaricus blazei.
Ziliotto L; Pinheiro F; Barbisan LF; Rodrigues MA
Nutr Cancer; 2009; 61(2):245-50. PubMed ID: 19235041
[TBL] [Abstract][Full Text] [Related]
13. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
Choi MS; Oh JH; Kim SM; Jung HY; Yoo HS; Lee YM; Moon DC; Han SB; Hong JT
Int J Oncol; 2009 May; 34(5):1221-30. PubMed ID: 19360335
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
Yu CH; Kan SF; Pu HF; Jea Chien E; Wang PS
Cancer Sci; 2008 Dec; 99(12):2467-76. PubMed ID: 19037992
[TBL] [Abstract][Full Text] [Related]
16. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro effect of baicalein on human prostate cancer cells.
Miocinovic R; McCabe NP; Keck RW; Jankun J; Hampton JA; Selman SH
Int J Oncol; 2005 Jan; 26(1):241-6. PubMed ID: 15586246
[TBL] [Abstract][Full Text] [Related]
18. The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation.
Siddiqui EJ; Shabbir M; Mikhailidis DP; Thompson CS; Mumtaz FH
J Urol; 2006 Oct; 176(4 Pt 1):1648-53. PubMed ID: 16952708
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effects of Agaricus blazei Murill in Balb/cByJ mice.
Chan Y; Chang T; Chan CH; Yeh YC; Chen CW; Shieh B; Li C
J Microbiol Immunol Infect; 2007 Jun; 40(3):201-8. PubMed ID: 17639159
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo.
Karsenty G; Rocha J; Chevalier S; Scarlata E; Andrieu C; Zouanat FZ; Rocchi P; Giusiano S; Elzayat EA; Corcos J
Prostate; 2009 Aug; 69(11):1143-50. PubMed ID: 19399787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
